Cargando…
Biomarker Jeopardy
In the popular Biomarker Jeopardy session, Sandra E. Kurtin, PhD, ANP-C, AOCN®, Alyssa Henglefelt, PharmD, BCOP, and Haleigh Mistry, MS, PA-C, paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure comm...
Autores principales: | Kurtin, Sandra E., Henglefelt, Alyssa, Mistry, Haleigh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126352/ https://www.ncbi.nlm.nih.gov/pubmed/35663183 http://dx.doi.org/10.6004/jadpro.2022.13.3.22 |
Ejemplares similares
-
Biomarker Jeopardy
por: Kurtin, Sandra E., et al.
Publicado: (2021) -
Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
por: Faiman, Beth, et al.
Publicado: (2023) -
Biomarker BINGO
por: Held, Lauren, et al.
Publicado: (2020) -
Optimizing Treatment of Chronic Lymphocytic Leukemia
por: Kurtin, Sandra E.
Publicado: (2021) -
A Deeper Dive Into Advanced and Future Directions in Treating Patients With Acute Myeloid Leukemia
por: Kurtin, Sandra E., et al.
Publicado: (2018)